XLON
FEVR
Market cap1.25bUSD
Oct 09, Last price
858.50GBP
1D
1.60%
1Q
10.42%
Jan 2017
-24.63%
IPO
420.30%
Name
Fevertree Drinks PLC
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Fevertree Drinks Plc, through its network of subsidiaries, specializes in crafting and distributing high-quality mixer beverages across the globe, with significant presence in the United Kingdom, the United States, and wider European regions. Its extensive product portfolio features a variety of sophisticated options, such as Indian, Mediterranean, elderflower, and Clementine tonic waters, alongside ginger beer, ginger ale, and a proprietary cola blend. These distinct offerings are marketed under the prominent Fever-Tree brand and primarily supplied to hospitality establishments like pubs, bars, and restaurants. The firm, initially named Fevertree Topco Limited, officially adopted its current designation, Fevertree Drinks Plc, in October 2014. Established in 2013, its main corporate office is situated in London, United Kingdom.
Related entities
Subsidiaries
FEVERTREE LIMITED
Key people
Timothy Warrillow
Chief Executive Officer, Co-Founder, Executive Director
Andrew Branchflower
Chief Financial Officer, Executive Director · since 2019
Alex O'connell
Company Secretary · since 2023
Domenic De Lorenzo
Non-Executive Independent Chairman of the Board · since 2023
Independent Non-Executive Director · since 2021
Senior Independent Non-Executive Director · since 2023
David Lapp
Independent Non-Executive Director · since 2024
Clare Lester-Swindell
Independent Non-Executive Director · since 2023
Jeff Popkin
Independent Non-executive Director · since 2018
Headquarters & legal address
186-188 SHEPHERDS BUSH ROAD
LONDON, LND W6 7NL
GB
LONDON, LND W6 7NL
GB
Previous name
FEVERTREE DRINKS LIMITED
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||